Sporovetin

Sporovetin contains spore bacteria Bacillus subtilis 12B, at least 1x10*6 living microbial cells and filler. The drug is characterized by high antagonistic activity against pathogenic and opportunistic microorganisms, namely:

• Sporovetin has a beneficial effect not only in the gastrointestinal tract, but also affects pathological foci localized in any other organ or system of the body.
• It has an antifungal effect against various mycoses of animals, including microsporia and trichophytosis.
• It has been proven that spore-forming bacteria can help not only with bacterial and viral infections, but also with the complex treatment of patients suffering from intestinal parasitic diseases.
• After entering the gastrointestinal tract, probiotic bacteria begin to produce biologically active substances that lyse pathogenic and opportunistic microorganisms. They synthesize a number of enzymes: amylase, protease, lipase, hemicellulase and others, due to which gastric secretions are enriched with additional enzymes and digestion processes are normalized.
• Bacterial enzymes are capable of destroying toxic substances, as well as food or microbial allergens, providing an anti-inflammatory, antitoxic effect.

Preparations from bacteria of the genus Bacillus, including Sporovetin, have a comprehensive preventive effect on the body.
Can be used daily.